BP’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,509
| Closed | -$376K | – | 79 |
|
|
2021
Q2 | $376K | Sell |
4,509
-1,924
| -30% | -$160K | 0.02% | 487 |
|
|
2021
Q1 | $486K | Sell |
6,433
-1,802
| -22% | -$136K | 0.02% | 477 |
|
|
2020
Q4 | $721K | Sell |
8,235
-8,865
| -52% | -$776K | 0.02% | 411 |
|
|
2020
Q3 | $1.3M | Sell |
17,100
-1,400
| -8% | -$106K | 0.03% | 377 |
|
|
2020
Q2 | $2.28M | Hold |
18,500
| – | – | 0.08% | 252 |
|
|
2020
Q1 | $1.56M | Hold |
18,500
| – | – | 0.07% | 282 |
|
|
2019
Q4 | $1.56M | Buy |
+18,500
| New | +$1.56M | 0.05% | 347 |
|
|
2019
Q1 | – | Sell |
-19,000
| Closed | -$1.62M | – | 390 |
|
|
2018
Q4 | $1.62M | Sell |
19,000
-3,000
| -14% | -$256K | 0.07% | 285 |
|
|
2018
Q3 | $2.13M | Hold |
22,000
| – | – | 0.07% | 300 |
|
|
2018
Q2 | $2.07M | Buy |
+22,000
| New | +$2.07M | 0.07% | 305 |
|
|
2018
Q1 | – | Sell |
-20,000
| Closed | -$1.78M | – | 431 |
|
|
2017
Q4 | $1.78M | Hold |
20,000
| – | – | 0.06% | 316 |
|
|
2017
Q3 | $1.86M | Hold |
20,000
| – | – | 0.07% | 305 |
|
|
2017
Q2 | $1.82M | Hold |
20,000
| – | – | 0.07% | 303 |
|
|
2017
Q1 | $1.76M | Hold |
20,000
| – | – | 0.07% | 309 |
|
|
2016
Q4 | $1.66M | Hold |
20,000
| – | – | 0.06% | 331 |
|
|
2016
Q3 | $1.85M | Buy |
+20,000
| New | +$1.85M | 0.07% | 293 |
|
|
2015
Q4 | – | Sell |
-16,000
| Closed | -$1.68M | – | 289 |
|
|
2015
Q3 | $1.68M | Sell |
16,000
-5,000
| -24% | -$526K | 0.08% | 249 |
|
|
2015
Q2 | $2.87M | Hold |
21,000
| – | – | 0.11% | 222 |
|
|
2015
Q1 | $2.62M | Buy |
+21,000
| New | +$2.62M | 0.08% | 245 |
|